Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2008
06/05/2008WO2008066887A2 Small molecule inhibitors of bcl6
06/05/2008WO2008066862A2 Methods of diagnosing and alleviating gadolinium toxicity
06/05/2008WO2008066845A2 Treatment of metabolic syndrome with norfluoxetine
06/05/2008WO2008066807A1 Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
06/05/2008WO2008066803A2 Substituted piperizines for the treatment of pain
06/05/2008WO2008066783A2 Therapeutic materials and methods
06/05/2008WO2008066775A2 Compositions and methods to reduce fat and retract skin
06/05/2008WO2008066770A2 Ace2 activator compounds and methods of use thereof
06/05/2008WO2008066755A2 Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents
06/05/2008WO2008066750A1 Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism
06/05/2008WO2008066745A1 Prophlyaxis and treatment of atrial fibrillation with omega-3 fatty acids
06/05/2008WO2008066704A2 Method of improving bioavailability for non-sedating barbiturates
06/05/2008WO2008066664A2 Cis-cyclohexyl substituted pyrimidinone derivatives
06/05/2008WO2008066634A2 Method of treqatment and compositions of d-chriro inositol and phosphates thereof
06/05/2008WO2008066627A2 Adenosine signaling in diagnosis, treatment and prevention of priapism and erectile dysfunction
06/05/2008WO2008066620A2 Dibenzothiazepine derivatives
06/05/2008WO2008066618A2 Antifungal composition and methods for using
06/05/2008WO2008066603A2 S-nitrosothiol compounds and related derivatives
06/05/2008WO2008066576A2 Methods for screening antimicrobial and antiviral compounds and uses thereof
06/05/2008WO2008066483A1 Use of nalp5 in methods for diagnosis and therapy of parathyroid related disorders
06/05/2008WO2008066402A1 Use of malachite green in the form of drug for treating malignant neoplasms
06/05/2008WO2008066353A1 Pharmaceutical composition comprising metadoxine and garlic oil for preventing and treating alcohol-induced fatty liver and steatohepatitis
06/05/2008WO2008066301A1 Anticancer composition containing naphthoquinone-based compound for intestine delivery system
06/05/2008WO2008066300A1 Naphthoquinone-based pharmaceutical composition for treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
06/05/2008WO2008066299A1 Pharmaceutical composition for the treatment and prevention of diseases involving impotence
06/05/2008WO2008066298A1 Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the same
06/05/2008WO2008066297A1 Pharmaceutical composition for treatment and prevention of restenosis
06/05/2008WO2008066296A1 Pharmaceutical composition containing phenanthrenequinone-based compound for intestine delivery system
06/05/2008WO2008066295A1 Pharmaceutical composition containing naphthoquinone-based compound for intestine delivery system
06/05/2008WO2008066294A1 Pharmaceutical composition containing micronized particle of naphthoquinone-based compound
06/05/2008WO2008066250A1 Ampk potentiator containing chito-oligosaccharide
06/05/2008WO2008066185A1 Method for prevention of discoloration with time of donepezil-containing skin adhesive preparation
06/05/2008WO2008066184A1 Method for prevention of coloration in donepezil-containing skin adhesive preparation, and method for reducing the production of donepezil analogue in donepezil-containing skin adhesive preparation
06/05/2008WO2008066183A1 Skin adhesive preparation comprising stabilized donepezil
06/05/2008WO2008066180A1 Skin adhesive preparation comprising stabilized donepezil
06/05/2008WO2008066179A1 Percutaneous absorption preparation
06/05/2008WO2008066151A1 Novel curcumin derivative
06/05/2008WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor
06/05/2008WO2008066131A1 Novel phenyl-isoxazol-3-ol derivative
06/05/2008WO2008066117A1 Cyclic amine compound
06/05/2008WO2008066102A1 Sustained release preparation
06/05/2008WO2008066097A1 Carboxylic acid derivative
06/05/2008WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion
06/05/2008WO2008066032A1 Lymphangiogenesis inhibitory factor
06/05/2008WO2008066026A1 Therapeutic agent for diabetes
06/05/2008WO2008065891A1 Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient
06/05/2008WO2008065796A1 α-GLUCOSIDASE INHIBITOR
06/05/2008WO2008065754A1 Substituted carbinol compound
06/05/2008WO2008065726A1 Telomelysin-containing agent for breaking antitumor tolerance
06/05/2008WO2008065674A1 Preparation of a free flowing molecular dispersion of clopidogrel base
06/05/2008WO2008065666A2 Uses of incensole, incensole acetate and derivatives thereof
06/05/2008WO2008065637A1 Treatment of disease
06/05/2008WO2008065636A2 Treatment of disease by modulating cf5 protein
06/05/2008WO2008065626A2 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors
06/05/2008WO2008065527A2 Gallic acid esters of fragrant alcohols
06/05/2008WO2008065514A2 Pharmaceutical compositions containing anhydrous calcipotriene
06/05/2008WO2008065508A1 Spiroketone acetyl-coa carboxylase inhibitors
06/05/2008WO2008065506A2 Pharmaceutical compositions comprising nanoparticles comprising enteric polymers and casein
06/05/2008WO2008065503A1 (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [ ( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor
06/05/2008WO2008065502A1 Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
06/05/2008WO2008065500A2 Heteroaryl amides as type i glycine transport inhibitors
06/05/2008WO2008065493A1 Pyrazole analogs
06/05/2008WO2008065445A1 Amino quinazolines derivatives wuth blood platelet reducing properties
06/05/2008WO2008065431A1 Ramipril-amine salts
06/05/2008WO2008065428A2 Steroid sulphatase inhibitors for treating hormone dependent cancer
06/05/2008WO2008065424A1 Ramipril-amlodipine salt
06/05/2008WO2008065421A1 Ramipril-metal salts
06/05/2008WO2008065417A1 Ramipril-amino acid salts
06/05/2008WO2008065409A2 Combination for use in the treatment of cancer, comprising tamoxifen or an aromatase inhibitor
06/05/2008WO2008065393A1 Hydantoin derivatives used as mmp inhibitors
06/05/2008WO2008065386A1 Treatment of disease
06/05/2008WO2008065370A2 Sesquiterpenoid modifying enzymes
06/05/2008WO2008065316A2 Ointment compositions comprising a vitamin d derivative
06/05/2008WO2008065306A1 Benzoyl peroxyde comprising compositions, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use
06/05/2008WO2008065304A1 New drug for inhibiting, preventing or treatment of rheumatoid arthritis
06/05/2008WO2008065247A1 Use of beta-lactamase
06/05/2008WO2008065199A1 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
06/05/2008WO2008065198A1 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases
06/05/2008WO2008065193A1 Combination product containing n-desmethylsertraline, or a salt thereof, and an antineoplastic agent for the treatment of cancer
06/05/2008WO2008065155A1 Cdk inhibitors for treating pain
06/05/2008WO2008065142A1 Stabilized solution of rocuronium comprising a sulfoalkyl-ether-beta-cyclodextrin derivative
06/05/2008WO2008065141A1 Novel inhibitors of glutaminyl cyclase
06/05/2008WO2008065107A1 Storage stable tablets based on benzimidazole derivatives coated with a gastro-resistant film
06/05/2008WO2008065100A1 Substituted estratrien derivatives as 17beta hsd inhibitors
06/05/2008WO2008065097A2 Stabilized solid pharmaceutical composition of candesartan cilexetil
06/05/2008WO2008065054A1 Tricyclic indoles and (4,5-dihydro) indoles
06/05/2008WO2008065044A1 Use of phosphoenolpyruvate derivatives for treating necrosis of cardiac muscle tissue
06/05/2008WO2008065021A1 Diaminocyclohexane and diaminocyclopentane derivatives
06/05/2008WO2008064916A2 Agent for treating vascular leaks
06/05/2008WO2008064866A1 Treatment for multiple myeloma
06/05/2008WO2008064854A1 Drug preparation of tramadol and acetaminophen
06/05/2008WO2008064849A1 Crystalline forms of zoledronic acid
06/05/2008WO2008064830A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their pharmaceutical uses
06/05/2008WO2008064829A2 Novel aminothienopyridinone derivatives processes for preparing them and pharmaceutical compositions thereof
06/05/2008WO2008064823A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
06/05/2008WO2008064815A2 Preparation for transdermally administering galanthamine
06/05/2008WO2008064789A1 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
06/05/2008WO2008064788A1 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
06/05/2008WO2008064615A2 Crystalline and amorphous forms of rimonabant and processes for obtaining them
06/05/2008WO2008064595A1 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide
1 ... 3233 3234 3235 3236 3237 3238 3239 3240 3241 3242 3243 3244 3245 3246 3247 3248 3249 3250 3251 3252 3253 ... 7860